GO:0051050
|
positive regulation of transport
|
1.51E-05
|
7.07E-04
|
4.62E-04
|
0.283
|
37%
|
490
|
GO:0023014
|
signal transduction by protein phosphorylation
|
1.51E-05
|
7.07E-04
|
4.62E-04
|
0.262
|
37%
|
472
|
GO:0061024
|
membrane organization
|
1.51E-05
|
7.07E-04
|
4.62E-04
|
0.303
|
44%
|
467
|
GO:0050778
|
positive regulation of immune response
|
1.52E-05
|
7.07E-04
|
4.62E-04
|
0.297
|
39%
|
464
|
GO:0002274
|
myeloid leukocyte activation
|
1.52E-05
|
7.07E-04
|
4.62E-04
|
0.425
|
46%
|
459
|
GO:0044257
|
cellular protein catabolic process
|
1.52E-05
|
7.07E-04
|
4.62E-04
|
0.279
|
37%
|
451
|
GO:0031347
|
regulation of defense response
|
1.52E-05
|
7.07E-04
|
4.62E-04
|
0.287
|
41%
|
444
|
GO:0017144
|
drug metabolic process
|
1.53E-05
|
7.07E-04
|
4.62E-04
|
0.277
|
32%
|
430
|
GO:0019221
|
cytokine-mediated signaling pathway
|
1.53E-05
|
7.07E-04
|
4.62E-04
|
0.282
|
41%
|
425
|
GO:0002444
|
myeloid leukocyte mediated immunity
|
1.54E-05
|
7.07E-04
|
4.62E-04
|
0.448
|
47%
|
405
|
GO:0002275
|
myeloid cell activation involved in immune response
|
1.54E-05
|
7.07E-04
|
4.62E-04
|
0.447
|
47%
|
398
|
GO:0098657
|
import into cell
|
1.54E-05
|
7.07E-04
|
4.62E-04
|
0.334
|
46%
|
396
|
GO:0043299
|
leukocyte degranulation
|
1.54E-05
|
7.07E-04
|
4.62E-04
|
0.451
|
48%
|
394
|
GO:0036230
|
granulocyte activation
|
1.55E-05
|
7.07E-04
|
4.62E-04
|
0.462
|
49%
|
381
|
GO:0042119
|
neutrophil activation
|
1.55E-05
|
7.07E-04
|
4.62E-04
|
0.461
|
49%
|
378
|
GO:0002446
|
neutrophil mediated immunity
|
1.55E-05
|
7.07E-04
|
4.62E-04
|
0.463
|
49%
|
377
|
GO:0002283
|
neutrophil activation involved in immune response
|
1.55E-05
|
7.07E-04
|
4.62E-04
|
0.466
|
49%
|
370
|
GO:0043312
|
neutrophil degranulation
|
1.55E-05
|
7.07E-04
|
4.62E-04
|
0.466
|
49%
|
370
|
GO:0006897
|
endocytosis
|
1.55E-05
|
7.07E-04
|
4.62E-04
|
0.331
|
46%
|
367
|
GO:0002253
|
activation of immune response
|
1.56E-05
|
7.07E-04
|
4.62E-04
|
0.304
|
39%
|
368
|